Editorial: ADAM, ADAMTS and Astacin Proteases: Challenges and Breakthroughs in the -Omics Era
Front Mol Biosci
.
2021 Oct 12:8:780242.
doi: 10.3389/fmolb.2021.780242.
eCollection 2021.
Authors
Kazuhiro Yamamoto
1
,
Rens de Groot
2
,
Simone Dario Scilabra
3
,
Hang Fai Kwok
4
5
,
Salvatore Santamaria
6
Affiliations
1
Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
2
Institute of Cardiovascular Science, University College London, London, United Kingdom.
3
Proteomics Group of Fondazione Ri.MED, Department of Research IRCCS ISMETT, Palermo, Italy.
4
Cancer Centre, Faculty of Health Sciences, University of Macau, Macau, China.
5
MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau, China.
6
Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
PMID:
34712699
PMCID:
PMC8546316
DOI:
10.3389/fmolb.2021.780242
No abstract available
Keywords:
ADAM; ADAMTS; astacin; extracellar matrix; proteomics.
Publication types
Editorial
Grants and funding
FS/IBSRF/20/25032/BHF_/British Heart Foundation/United Kingdom